Second-Generation Antipsychotics and Extrapyramidal Adverse Effects

BioMed Research International - United States
doi 10.1155/2014/656370
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Second-Generation Antipsychotics and Metabolic Side-Effects: Canadian Population-Based Study

BJPsych Open
PsychiatryMental Health
2018English

Economic Grand Rounds: Economic Costs of Failure to Monitor Adverse Effects of Second-Generation Antipsychotics: An Underestimated Factor

Psychiatric Services
MedicinePsychiatryMental Health
2012English

Metabolic Monitoring of Psychiatric Patients on Second-Generation Antipsychotics

Annals of General Psychiatry
PsychiatryMental Health
2008English

Prevalence of Extrapyramidal Side Effects in Patients on Antipsychotics Drugs at a Tertiary Care Center5

Journal of Psychiatry
2017English

Effect of Second-Generation Antipsychotics on Cognition: Current Issues and Future Challenges

Expert Review of Neurotherapeutics
NeuroscienceNeurologyPharmacology
2010English

Reply to ‘Antipsychotics With Similar Association Kinetics at Dopamine D2 Receptors Differ in Extrapyramidal Side-Effects’

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Reproductive Safety of Second-Generation Antipsychotics: Current Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics

American Journal of Psychiatry
PsychiatryMental Health
2016English

Association Between Antipsychotics and Adverse Outcomes in Dementia

Progress in Neurology and Psychiatry
PsychiatryMental HealthNeurologyPsychiatric Mental Health
2017English

Second-Generation Antipsychotics and Metabolism Alterations: A Systematic Review of the Role of the Gut Microbiome

Psychopharmacology
Pharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy